Universal Vision Biotechnology Co., Ltd.(TW:3218)
NT$118.00-4.50 (-3.67%)
TW:3218
Universal Vision Biotechnology Co., Ltd. earnings date
NT$118.00
At close:-4.50 (-3.67%)
Universal Vision Biotechnology Co., Ltd. (3218) Q2 2023 Earnings Report
TW:3218 Q2 2023 EPS Results
- Actual EPS
- TWD 3.25
- Consensus EPS
- TWD 3.10
- Beat/Miss
- Beat by +TWD 0.15
- One Year Ago EPS
- TWD 2.32
TW:3218 Q2 2023 Revenue Results
- Actual Revenue
- TWD 999.40M
- Expected Revenue
- TWD 999.00M
- Beat/Miss
- Beat by +TWD 398.00K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/10/2023
- Time
- Before Open
- Conference Call
- Thursday, August 10, 2023
TW:3218 Upcoming Earnings
Universal Vision Biotechnology Co., Ltd.'s next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
TW:3218 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | ―- | 3.48 | ― | ― |
| Nov 18, 2026 | 2026 (Q3) | ―3.21 | 4.05 | -20.72% (-0.84) | |
| Aug 12, 2026 | 2026 (Q2) | 3.272.67 | 0.5 | 434.00% (+2.17) | |
| May 11, 2026 | 2026 (Q1) | 3.593.31 | 4.28 | -22.57% (-0.97) | |
| Mar 05, 2026 | 2025 (Q4) | 3.473.48 | 2.82 | 23.40% (+0.66) | |
| Nov 12, 2025 | 2025 (Q3) | 3.424.05 | 2.88 | 40.63% (+1.17) | |
| Aug 13, 2025 | 2025 (Q2) | 3.310.50 | 3.28 | -84.76% (-2.78) | |
| May 14, 2025 | 2025 (Q1) | 3.664.28 | 3.59 | 19.22% (+0.69) | |
| Mar 06, 2025 | 2024 (Q4) | 3.062.82 | 2.99 | -5.69% (-0.17) | |
| Nov 13, 2024 | 2024 (Q3) | 3.502.88 | 3.14 | -8.28% (-0.26) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

